Premium
Histone deacetylase inhibition reduces myocardial ischemia‐reperfusion injury in mice
Author(s) -
Granger Anne,
Abdullah Ibrahim,
Huebner Faith,
Stout Andrea,
Wang Tao,
Huebner Thomas,
Epstein Jonathan A.,
Gruber Peter J.
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.08-108548
Subject(s) - histone deacetylase , in vivo , medicine , myocardial infarction , ischemia , hdac1 , hdac4 , pharmacology , reperfusion injury , histone deacetylase 5 , gene knockdown , hypoxia (environmental) , in vitro , histone , cardioprotection , cardiology , chemistry , biology , apoptosis , biochemistry , gene , microbiology and biotechnology , organic chemistry , oxygen
Limitation of infarct size is a major goal of therapy for acute coronary syndromes, and research has focused on achieving rapid patency of infarct‐related vessels. However, new understandings of epigenetic modifications during ischemia suggest additional targeted approaches that have not been extensively explored. Here, we show that ischemia induces histone deacetylase (HDAC) activity in the heart with deacetylation of histones H3/4 in vitro and in vivo. We show, utilizing a standard murine model of ischemia‐reperfusion, that chemical HDAC inhibitors significantly reduce infarct area, even when delivered 1 h after the ischemic insult. We demonstrate that HDAC inhibitors prevent ischemia‐induced activation of gene programs that include hypoxia inducible factor‐1α, cell death, and vascular permeability in vivo and in vitro , thus providing potential mechanisms to explain reduced vascular leak and myocardial injury. In vitro , siRNA knockdown experiments implicate HDAC4 as a mediator of the effects in ischemic cardiac myocytes. These results demonstrate that HDAC inhibitors alter the response to ischemic injury in the heart and reduce infarct size, suggesting novel therapeutic approaches for acute coronary syndromes.—Granger, A., Abdullah, I., Huebner, F., Stout, A., Wang, T., Huebner, T., Epstein, J. A., Gruber, P. J. Histone deacetylase inhibition reduces myocardial ischemia‐reperfusion injury in mice. FASEB J. 22, 3549–3560 (2008)